Therapeutic Cloning in Medicine of the Future

Therapeutic cloning: Future medicine When most people hear the word clone, they are not considering treating illness or serious injury. Instead, what comes to mind is the same copy of a person created in the laboratory. However, this is rarely mentioned by scientists when using this term. What they are talking about is a very different process called therapeutic cloning. In this process, humans of a particular cell type can be cloned and integrated into the body for medical use.

Two common theoretical human clonal types are therapeutic cloning and reproductive cloning. Therapeutic cloning involves the use of human cloned cells for medicine and transplantation and is an active area of ​​research, but by 2014 there was no medical practice anywhere in the world. Two commonly used therapeutic cloning methods under investigation are somatic cell nuclear transfer, and recent pluripotent stem cell induction. Reproductive cloning involves the creation of specific cells and tissues as well as whole clones.

There are two types of cloning, therapeutic and reproductive. Therapeutic cloning involves cloning cells from adults for medical and medical research. Reproductive cloning is a totally different problem, which creates identical copies of humans and is very controversial. Reproductive cloning has not yet been done to humans, it is illegal in most countries. The gene selection program can be applied after testing the fetus or embryo by prenatal screening or preimplantation genetic diagnosis (PGD). PGD ​​examines embryonic gene sequences related to specific medical conditions. Cells were extracted from the embryos at the eighth cell stage and analyzed. Embryos with selected characteristics can be transplanted into the womb's uterus to grow to children.

The next category is a therapeutic clone. Therapeutic cloning is the use of clones for therapeutic purposes. This cloning technique involves the development of human embryos. The purpose of cloning is not to clone humans, but to use cloned embryos for research and therapeutic purposes. When a nuclear transplant occurs, this technique is formed and the eggs become feasible. After that, blastocysts formed after 5 days. Blastocysts contain stem cells in their internal structure. Stem cell collection is the ultimate goal of therapeutic cloning. Stem cells can be used to produce almost any kind of specialized cells within the human body. The end result of this technique is that it becomes the number of alternative organs, nerve tissue pieces, or skin. The first successful therapeutic clone was completed by Advanced Cell Technology, a biotechnology company based in Worcester, Massachusetts from November to November.